XPER Fundamental Analysis - XPERI INC

Fundamental Rating

Taking everything into account, XPER scores 3 out of 10 in our fundamental rating. XPER was compared to 283 industry peers in the Software industry. XPER scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XPER has a decent growth rate and is not valued too expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year XPER was profitable.

In the past year XPER has reported a negative cash flow from operations.

In the past 5 years XPER always reported negative net income.

In the past 5 years XPER reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -0.59%, XPER is in line with its industry, outperforming 57.75% of the companies in the same industry.

XPER has a Return On Equity of -0.89%. This is comparable to the rest of the industry: XPER outperforms 59.86% of its industry peers.

		Industry Rank	Sector Rank
ROA	-0.59%
ROE	-0.89%
ROIC	N/A

ROA(3y)-41.72%

ROA(5y)-29.98%

ROE(3y)-66.84%

ROE(5y)-46.08%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 75.13%, XPER is doing good in the industry, outperforming 66.90% of the companies in the same industry.

In the last couple of years the Gross Margin of XPER has declined.

XPER does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	75.13%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.23%

GM growth 5Y-4.34%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

XPER does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, XPER has more shares outstanding

XPER has less shares outstanding than it did 5 years ago.

Compared to 1 year ago, XPER has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.29, we must say that XPER is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -0.29, XPER is doing worse than 73.59% of the companies in the same industry.

XPER has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of XPER (0.10) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	N/A
Altman-Z	-0.29

ROIC/WACCN/A

WACC11.11%

2.3 Liquidity

XPER has a Current Ratio of 2.50. This indicates that XPER is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 2.50, XPER is in the better half of the industry, outperforming 70.42% of the companies in the same industry.

A Quick Ratio of 2.50 indicates that XPER has no problem at all paying its short term obligations.

XPER's Quick ratio of 2.50 is fine compared to the rest of the industry. XPER outperforms 70.42% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.5
Quick Ratio	2.5

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

XPER shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1070.00%, which is quite impressive.

XPER shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.24% yearly.

XPER shows a decrease in Revenue. In the last year, the revenue decreased by -6.10%.

Measured over the past years, XPER shows a very strong growth in Revenue. The Revenue has been growing by 20.04% on average per year.

EPS 1Y (TTM)1070%

EPS 3Y-21.82%

EPS 5Y-21.24%

EPS Q2Q%-8.33%

Revenue 1Y (TTM)-6.1%

Revenue growth 3Y0.49%

Revenue growth 5Y20.04%

Sales Q2Q%-11.42%

3.2 Future

Based on estimates for the next years, XPER will show a decrease in Earnings Per Share. The EPS will decrease by -4.90% on average per year.

The Revenue is expected to decrease by -2.28% on average over the next years.

EPS Next Y-21.73%

EPS Next 2Y-4.9%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-9.66%

Revenue Next 2Y-2.28%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.65, the valuation of XPER can be described as very cheap.

Based on the Price/Earnings ratio, XPER is valued cheaper than 95.42% of the companies in the same industry.

When comparing the Price/Earnings ratio of XPER to the average of the S&P500 Index (27.40), we can say XPER is valued rather cheaply.

Based on the Price/Forward Earnings ratio of 7.54, the valuation of XPER can be described as very cheap.

95.07% of the companies in the same industry are more expensive than XPER, based on the Price/Forward Earnings ratio.

The average S&P500 Price/Forward Earnings ratio is at 22.94. XPER is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	5.65
Fwd PE	7.54

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as XPER's earnings are expected to decrease with -4.90% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-4.9%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for XPER!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

XPERI INC

NYSE:XPER (10/17/2025, 8:04:00 PM)

After market: 6.61 0 (0%)

6.61

-0.11 (-1.64%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)08-06 2025-08-06/amc

Earnings (Next)11-05 2025-11-05/amc

Inst Owners92.96%

Inst Owner Change1.08%

Ins Owners3.07%

Ins Owner Change3.73%

Market Cap305.78M

Analysts82

Price Target11.22 (69.74%)

Short Float %5.03%

Short Ratio4.41

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)313.46%

Min EPS beat(2)13.91%

Max EPS beat(2)613.01%

EPS beat(4)4

Avg EPS beat(4)217.88%

Min EPS beat(4)13.91%

Max EPS beat(4)613.01%

EPS beat(8)8

Avg EPS beat(8)190.07%

EPS beat(12)12

Avg EPS beat(12)151.25%

EPS beat(16)15

Avg EPS beat(16)120.26%

Revenue beat(2)0

Avg Revenue beat(2)-4.82%

Min Revenue beat(2)-8.36%

Max Revenue beat(2)-1.28%

Revenue beat(4)0

Avg Revenue beat(4)-3.29%

Min Revenue beat(4)-8.36%

Max Revenue beat(4)-0.34%

Revenue beat(8)0

Avg Revenue beat(8)-3.15%

Revenue beat(12)1

Avg Revenue beat(12)-2.81%

Revenue beat(16)1

Avg Revenue beat(16)-13.91%

PT rev (1m)0%

PT rev (3m)-39.73%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-4.13%

EPS NY rev (1m)-11.14%

EPS NY rev (3m)-24.51%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-9.78%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-8.03%

Valuation

		Industry Rank	Sector Rank
PE	5.65
Fwd PE	7.54
P/S	0.64
P/FCF	N/A
P/OCF	N/A
P/B	0.73
P/tB	1.11
EV/EBITDA	N/A

EPS(TTM)1.17

EY17.7%

EPS(NY)0.88

Fwd EY13.27%

FCF(TTM)-0.72

FCFYN/A

OCF(TTM)-0.34

OCFYN/A

SpS10.27

BVpS9.08

TBVpS5.94

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.59%
ROE	-0.89%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	75.13%
FCFM	N/A

ROA(3y)-41.72%

ROA(5y)-29.98%

ROE(3y)-66.84%

ROE(5y)-46.08%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.23%

GM growth 5Y-4.34%

F-Score4

Asset Turnover0.76

Health

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	33.89%
Cap/Sales	3.73%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.5
Quick Ratio	2.5
Altman-Z	-0.29

F-Score4

WACC11.11%

ROIC/WACCN/A

Cap/Depr(3y)21.67%

Cap/Depr(5y)15.65%

Cap/Sales(3y)2.93%

Cap/Sales(5y)2.5%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)1070%

EPS 3Y-21.82%

EPS 5Y-21.24%

EPS Q2Q%-8.33%

EPS Next Y-21.73%

EPS Next 2Y-4.9%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-6.1%

Revenue growth 3Y0.49%

Revenue growth 5Y20.04%

Sales Q2Q%-11.42%

Revenue Next Year-9.66%

Revenue Next 2Y-2.28%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y48.59%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year631.08%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y48.13%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y69.37%

OCF growth 3YN/A

OCF growth 5YN/A

XPERI INC (XPER) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens